World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
23828
World Ranking
14707
National Ranking
7440

Overview

Gary E. Gallick was affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research contributions primarily focused on medicine and biochemistry, genetics, and molecular biology, with significant work spanning multiple subfields including molecular biology, pulmonary and respiratory medicine, cancer research, oncology, and rheumatology.

The scientific work of Gary E. Gallick covered several topics, notably in the areas of prostate cancer treatment and research, bone health and treatments, RNA research and splicing, bone and dental protein studies, extracellular vesicles in disease, Hippo pathway signaling and YAP/TAZ, and fibroblast growth factor research.

Frequent coauthors in their collaborations included:

  • Jian H. Song
  • Christopher J. Logothetis
  • Theocharis Panaretakis
  • Guoyu Yu
  • Sue-Hwa Lin

Gary E. Gallick published in various scientific venues with multiple publications in Clinical Cancer Research, as well as contributions to Cancers, iScience, Molecular Cancer Therapeutics, and Oncogene.

Selected recent papers authored or coauthored by Gary E. Gallick include:

  • Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment, 2021, Clinical Cancer Research
  • Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer, 2020, Cancers
  • A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer, 2020, Clinical Cancer Research
  • Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4, 2021, iScience
  • Cabozantinib Reverses Renal Cell Carcinoma-mediated Osteoblast Inhibition in Three-dimensional Coculture In Vitro and Reduces Bone Osteolysis In Vivo, 2020, Molecular Cancer Therapeutics

Best Publications

  • Src family kinases in tumor progression and metastasis

    Justin M. Summy;Gary E. Gallick

  • Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

    Thiruvengadam Arumugam;Vijaya Ramachandran;Keith Francis Fournier;Huamin Wang

  • BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

    Nicholas J. Donato;Ji Yuan Wu;Jonathan Stapley;Gary Gallick

  • Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway

    Zhiwei Wang;Yiwei Li;Dejuan Kong;Sanjeev Banerjee

  • Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer

    Mark S. Talamonti;Mark S. Roh;Steven A. Curley;Gary E. Gallick

  • Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells

    Ami N. Shah;Justin M. Summy;Jing Zhang;Serk In Park

  • HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas

    Michael J Gray;Jing Zhang;Jing Zhang;Lee M Ellis;Gregg L Semenza

  • EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.

    Y. D. Jung;Y. D. Jung;M. S. Kim;B. A. Shin;K. O. Chay

  • Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice

    Michael P Kim;Douglas B Evans;Huamin Wang;James L Abbruzzese

  • Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents

    Muling Mao;Feng Tian;John M. Mariadason;Chun C. Tsao

  • Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis.

    Heike Allgayer M.D.;Douglas D. Boyd;Markus M. Heiss;Eddie K. Abdalla

  • Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src

    Lee M. Ellis;Charles A. Staley;Wenbiao Liu;R. Y. Declan Fleming

  • ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma

    Michael P. Kim;Jason B. Fleming;Huamin Wang;James L Abbruzzese

  • Treatment for Advanced Tumors: Src Reclaims Center Stage

    Justin M. Summy;Gary E. Gallick

  • Src activation regulates anoikis in human colon tumor cell lines.

    T Christopher Windham;Nila U Parikh;Doris R Siwak;Justin M Summy

  • Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor.

    E. Ramsay Camp;Justin Summy;Todd W. Bauer;Wenbiao Liu

  • Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features.

    Mahitosh Mandal;Jeffery N. Myers;Scott M. Lippman;Faye M. Johnson

  • A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis

    Chunlai Li;Shouyu Wang;Zhen Xing;Aifu Lin

  • Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model.

    Serk In Park;Jing Zhang;Kacy A. Phillips;John C. Araujo

  • Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival.

    Niels Reinmuth;Wenbiao Liu;Young D. Jung;Syed A. Ahmad

Frequent Co-Authors

Christopher J. Logothetis
Christopher J. Logothetis The University of Texas MD Anderson Cancer Center
Lee M. Ellis
Lee M. Ellis The University of Texas MD Anderson Cancer Center
Anil K. Sood
Anil K. Sood The University of Texas MD Anderson Cancer Center
Scott Kopetz
Scott Kopetz The University of Texas MD Anderson Cancer Center
Gabriel Lopez-Berestein
Gabriel Lopez-Berestein The University of Texas MD Anderson Cancer Center
James L. Abbruzzese
James L. Abbruzzese Duke University
Douglas B. Evans
Douglas B. Evans Medical College of Wisconsin
Corazon D. Bucana
Corazon D. Bucana The University of Texas MD Anderson Cancer Center
Jordan U. Gutterman
Jordan U. Gutterman The University of Texas MD Anderson Cancer Center
David J. McConkey
David J. McConkey Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA opens up a variety of related degree options and career pathways beyond the traditional MD. Many students consider alternative routes into the healthcare field through specialized online programs tailored to meet diverse needs and interests.

For those seeking a quicker entry into nursing, fast track lpn programs online provide a streamlined path to becoming a Licensed Practical Nurse. These programs can often be completed in under a year, offering a practical solution for individuals eager to start working in patient care roles.

If mental health interests you, consider the accelerated msn psychiatric np programs. These advanced degrees allow registered nurses to specialize as psychiatric mental health nurse practitioners, a role that’s in high demand across the country.

Students interested in non-clinical leadership roles may benefit from pursuing health administration degrees online. These programs offer flexibility and knowledge for managing healthcare systems or clinics. For an advanced option, the most affordable mha programs help professionals move into executive positions within healthcare organizations.

Best Scientists Citing Gary E. Gallick

Recently Published Articles